Indeed, treatment of IDH1-mutant AML with IACS-010759 has been reported to suppress aspartate levels40, consistent with a high demand for mitochondrial citrate that is required to support citrate levels in the cytosol for acetyl CoA production, fatty acid biosynthesis, acetylation of histones and other proteins57. The gene discussed is IDH1; the disease is acute myeloid leukemia.